• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Heliyon . Characterization of local SARS-CoV-2 isolates and pathogenicity in IFNAR -/- mice

tetano

Editor, Senior Moderator
Heliyon


. 2020 Sep;6(9):e05116.
doi: 10.1016/j.heliyon.2020.e05116. Epub 2020 Sep 29.
Characterization of local SARS-CoV-2 isolates and pathogenicity in IFNAR [SUP]-/-[/SUP] mice


Alireza Hanifehnezhad[SUP] 1 [/SUP], Ebru Şahin Kehribar[SUP] 2 [/SUP], Sıdıka ?ztop[SUP] 3 [/SUP], Ali Sheraz[SUP] 2 [/SUP], Serkan Kasırga[SUP] 2 [/SUP], Koray Erg?nay[SUP] 4 [/SUP], Sevgen ?nder[SUP] 5 [/SUP], Erkan Yılmaz[SUP] 6 [/SUP], Doruk Engin[SUP] 6 [/SUP], T ?iğdem Oğuzoğlu[SUP] 1 [/SUP], Urartu ?zg?r Şafak Şeker[SUP] 2 [/SUP], Engin Yılmaz[SUP] 7 [/SUP], Aykut ?zkul[SUP] 1 6 [/SUP]



Affiliations
Free PMC article

Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) recently a global pandemic with unprecedented public health, economic and social impact. The development of effective mitigation strategies, therapeutics and vaccines relies on detailed genomic and biological characterization of the regional viruses. This study was carried out to isolate SARS-CoV-2 viruses circulating in Anatolia, and to investigate virus propagation in frequently-used cells and experimental animals. We obtained two SARS-CoV-2 viruses from nasopharngeal swabs of confirmed cases in Vero E6 cells, visualized the virions using atomic force and scanning electron microscopy and determined size distribution of the particles. Viral cytopathic effects on Vero E6 cells were initially observed at 72 h post-inoculation and reached 90% of the cells on the 5th day. The isolates displayed with similar infectivity titers, time course and infectious progeny yields. Genome sequencing revealed the viruses to be well-conserved, with less than 1% diversity compared to the prototype virus. The analysis of the viral genomes, along with the available 62 complete genomes from Anatolia, showed limited diversity (up to 0.2% on deduced amino acids) and no evidence of recombination. The most prominent sequence variation was observed on the spike protein, resulting in the substitution D614G, with a prevalence of 56.2%. The isolates produced non-fatal infection in the transgenic type I interferon knockout (IFNAR[SUP]-/-[/SUP]) mice, with varying neutralizing antibody titers. Hyperemia, regional consolidation and subpleural air accumulation was observed on necropsy, with similar histopathological and immunohistochemistry findings in the lungs, heart, stomach, intestines, liver, spleen and kidneys. Peak viral loads were detected in the lungs, with virus RNA present in the kidneys, jejunum, liver, spleen and heart. In conclusion, we characterized two local isolates, investigated in vitro growth dynamics in Vero E6 cells and identified IFNAR-/- mice as a potential animal model for SARS-CoV-2 experiments.

Keywords: Bioinformatics; Epidemiology; Genome; IFNAR−/− mice; Isolate; Microbiology; Respiratory system; SARS-CoV-2; Viral disease; Viral genetics; Virology.
 
Back
Top Bottom